Chronic respiratory disease · 2026
Explainable machine learning model for predicting acute exacerbations of COPD combining sarcopenia index and traditional risk factors: A retrospective single-center exploratory study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Ai-Bin, Zhou Li-Wen, An Yu-Fen, Qin Qing-Qing, Wei Jian-Tong, Chen Hao
Аннотация
ObjectivesChronic obstructive pulmonary disease (COPD) is a common respiratory disorder. Acute exacerbation of COPD (AECOPD) severely affects patients' quality of life and prognosis. This study aimed to identify novel risk factors and develop an effective predictive model for AECOPD using machine learning (ML) models.MethodsIn this retrospective single-center study, clinical data and biomarkers from 565 participants were analyzed using ML algorithms. Feature selection employed least absolute shrinkage and selection operator regression. Eight ML models were trained and evaluated using receiver operating characteristic (ROC) and clinical decision curve analysis. The Shapley Additive explanations (SHAP) framework assessed feature contributions. An online personalized risk calculator was developed based on the optimal model and individual SHAP values.ResultsThe XGBoost model demonstrated excellent discriminative performance, with areas under the ROC curve of 0.818 and 0.838 for the training and test sets, respectively. Key predictors identified by SHAP analysis included age, current smoking status, frequency of exacerbations in the previous year, albumin levels, sarcopenia index, and COPD Assessment Test score. These variables were integrated into an online calculator for research to illustrate individualized AECOPD risk estimation. However, external validation is still required before its clinical application.ConclusionsWe developed a preliminary ML model for predicting AECOPD, which provides a valuable tool for clinical risk assessment. The results also highlighted the correlation between sarcopenia and AECOPD risk.